Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Understanding the Clinical Pharmacology of Marijuana-Tobacco Co-administration
NCT05999383Phase 2Recruiting
- Sponsor
- University of California, San Francisco
- Start
- Jul 2025
- Primary completion
- Feb 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of cannabis and nicotine (8 arms), sponsored by University of California, San Francisco. Primary endpoints: Peak plasma concentration of THC at Day 8 and Peak plasma concentration of nicotine at Day 8. Started Jul 2025; status: recruiting.
02
Drugs
cannabisnicotine
Beyond the preview
Go deeper on NCT05999383.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05999383.